Indrayani Biotech's Rights Issue Committee approved terms for a ₹49.9 crore rights issue of partly paid-up equity shares.
The issue involves 3.25 crore shares at ₹15 each, with a 5:7 entitlement ratio for existing shareholders.
Record date is April 28, 2026, with the issue opening May 27 and closing June 25, 2026.
Axis Bank is the banker and India Ratings is the monitoring agency for the issue.